|
Volumn 87, Issue 3, 2002, Pages 233-234
|
Thalidomide in multiple myeloma: State of art
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD34 ANTIGEN;
CYTOTOXIC AGENT;
DEXAMETHASONE;
IMMUNOMODULATING AGENT;
INTERLEUKIN 6;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA;
CLINICAL TRIAL;
CONSTIPATION;
EDITORIAL;
HUMAN;
IMMUNE RESPONSE;
LETHARGY;
MULTIPLE MYELOMA;
RASH;
TREATMENT OUTCOME;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE MYELOMA;
SALVAGE THERAPY;
THALIDOMIDE;
TREATMENT OUTCOME;
|
EID: 0036196843
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (9)
|
References (23)
|